- Home
- COYA vs PGAC Comparison
COYA vs PGAC Comparison
Compare COYA & PGAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- PGAC
- Stock Information
- Founded
- COYA 2020
- PGAC 2024
- Country
- COYA United States
- PGAC United States
- Employees
- COYA N/A
- PGAC N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- PGAC
- Sector
- COYA Health Care
- PGAC
- Exchange
- COYA Nasdaq
- PGAC Nasdaq
- Market Cap
- COYA 107.0M
- PGAC 112.8M
- IPO Year
- COYA 2022
- PGAC N/A
- Fundamental
- Price
- COYA $6.08
- PGAC $10.29
- Analyst Decision
- COYA Strong Buy
- PGAC
- Analyst Count
- COYA 4
- PGAC 0
- Target Price
- COYA $16.50
- PGAC N/A
- AVG Volume (30 Days)
- COYA 96.0K
- PGAC 52.9K
- Earning Date
- COYA 11-05-2025
- PGAC 08-14-2025
- Dividend Yield
- COYA N/A
- PGAC N/A
- EPS Growth
- COYA N/A
- PGAC N/A
- EPS
- COYA N/A
- PGAC N/A
- Revenue
- COYA $423,452.00
- PGAC N/A
- Revenue This Year
- COYA N/A
- PGAC N/A
- Revenue Next Year
- COYA N/A
- PGAC N/A
- P/E Ratio
- COYA N/A
- PGAC N/A
- Revenue Growth
- COYA N/A
- PGAC N/A
- 52 Week Low
- COYA $4.65
- PGAC $10.20
- 52 Week High
- COYA $10.24
- PGAC $10.29
- Technical
- Relative Strength Index (RSI)
- COYA 45.51
- PGAC N/A
- Support Level
- COYA $6.05
- PGAC N/A
- Resistance Level
- COYA $6.53
- PGAC N/A
- Average True Range (ATR)
- COYA 0.46
- PGAC 0.00
- MACD
- COYA -0.05
- PGAC 0.00
- Stochastic Oscillator
- COYA 12.69
- PGAC 0.00
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About PGAC Pantages Capital Acquisition Corporation Class A Ordinary Shares
Pantages Capital Acquisition Corp is a blank check company.